Barclays’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $2 | Buy |
+1
| New | +$3 | ﹤0.01% | 5303 |
|
|
2026
Q2 | – | Sell |
-224
| Closed | -$710 | – | 5381 |
|
|
2026
Q1 | $710 | Buy |
+224
| New | +$859 | ﹤0.01% | 4920 |
|
|
2023
Q4 | – | Sell |
-28
| Closed | -$44 | – | 5236 |
|
|
2023
Q3 | $44 | Hold |
28
| – | – | ﹤0.01% | 4558 |
|
|
2023
Q2 | $55 | Hold |
28
| – | – | ﹤0.01% | 4456 |
|
|
2023
Q1 | $54 | Hold |
28
| – | – | ﹤0.01% | 5013 |
|
|
2022
Q4 | $59 | Sell |
28
-622
| -96% | -$1.41K | ﹤0.01% | 5209 |
|
|
2022
Q3 | $1K | Buy |
+650
| New | +$1.97K | ﹤0.01% | 4679 |
|
|
2022
Q1 | – | Sell |
-2,324
| Closed | -$19K | – | 5018 |
|
|
2021
Q4 | $19K | Sell |
2,324
-41,264
| -95% | -$406K | ﹤0.01% | 3954 |
|
|
2021
Q3 | $549K | Sell |
43,588
-19,801
| -31% | -$274K | ﹤0.01% | 3141 |
|
|
2021
Q2 | $980K | Buy |
63,389
+40,173
| +173% | +$675K | ﹤0.01% | 2670 |
|
|
2021
Q1 | $469K | Buy |
23,216
+18,688
| +413% | +$462K | ﹤0.01% | 3215 |
|
|
2020
Q4 | $123K | Buy |
4,528
+4,043
| +834% | +$90.7K | ﹤0.01% | 4034 |
|
|
2020
Q3 | $9K | Buy |
+485
| New | +$8.61K | ﹤0.01% | 5023 |
|
|
2020
Q1 | – | Sell |
-71
| Closed | -$1K | – | 6164 |
|
|
2019
Q4 | $1K | Sell |
71
-290
| -80% | -$3.87K | ﹤0.01% | 6270 |
|
|
2019
Q3 | $4K | Buy |
361
+260
| +257% | +$3.5K | ﹤0.01% | 6471 |
|
|
2019
Q2 | $2K | Sell |
101
-1,131
| -92% | -$20.2K | ﹤0.01% | 6791 |
|
|
2019
Q1 | $23K | Buy |
1,232
+1,145
| +1,316% | +$20.3K | ﹤0.01% | 6292 |
|
|
2018
Q4 | $1K | Buy |
87
+1
| +1% | +$23 | ﹤0.01% | 6783 |
|
|
2018
Q3 | $2K | Sell |
86
-4,760
| -98% | -$137K | ﹤0.01% | 6929 |
|
|
2018
Q2 | $137K | Sell |
4,846
-6
| -0.1% | -$179 | ﹤0.01% | 5035 |
|
|
2018
Q1 | $152K | Buy |
4,852
+52
| +1% | +$1.64K | ﹤0.01% | 5066 |
|
|
2017
Q4 | $140K | Sell |
4,800
-10,300
| -68% | -$281K | ﹤0.01% | 4976 |
|
|
2017
Q3 | $430K | Buy |
+15,100
| New | +$391K | ﹤0.01% | 3767 |
|
|
2015
Q2 | – | Sell |
-90
| Closed | -$3K | – | 7028 |
|
|
2015
Q1 | $3K | Buy |
+90
| New | +$3.27K | ﹤0.01% | 6757 |
|
Other funds holding CLLS
PIS
Barclays's CLLS Position: Q3 2026 in Review
Barclays opened a new position in Cellectis (CLLS) in Q3 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #5303 among its holdings. This is a return to the name: Barclays previously reported a position in CLLS as recently as Q1 2026.
Barclays first reported a position in CLLS in Q1 2015 and has held it in 24 quarters since. The position peaked at $980K in Q2 2021. 9 funds tracked by Wall St. Rank hold CLLS as of Q3 2026.
- Barclays held 1 share of Cellectis worth $2 as of Q3 2026.
- Cellectis was a new Barclays position in Q3 2026.
- Cellectis made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5303 holding.
- Barclays first reported a position in Cellectis in Q1 2015 and has held it in 24 quarters since.
- Barclays's Cellectis position peaked at $980K in Q2 2021.
- 9 funds tracked by Wall St. Rank held Cellectis as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.